'Acquire 100% generic business in US for $550 mn'

Subhanu Saxena, MD and Global CEO of Cipla spoke to ET Now and stated that Cipla will acquire 100% generic business in US for $550 million. Acquisitions will give company scale in US generic market. Check out the video to know more on that.